V009-2585 Screening compound: 3-(4-ethylpiperazin-1-yl)-4-(5-hydroxy-1,3-diphenyl-1H-pyrazol-4-yl)-1-(4-methoxyphenyl)-2,5-dihydro-1H-pyrrole-2,5-dione

V009-2585 Screening compound: 3-(4-ethylpiperazin-1-yl)-4-(5-hydroxy-1,3-diphenyl-1H-pyrazol-4-yl)-1-(4-methoxyphenyl)-2,5-dihydro-1H-pyrrole-2,5-dione
V009-2585 Screening compound: 3-(4-ethylpiperazin-1-yl)-4-(5-hydroxy-1,3-diphenyl-1H-pyrazol-4-yl)-1-(4-methoxyphenyl)-2,5-dihydro-1H-pyrrole-2,5-dione alternative view

Chemical Structure Depiction of ChemDiv screening compound V009-2585
3-(4-ethylpiperazin-1-yl)-4-(5-hydroxy-1,3-diphenyl-1H-pyrazol-4-yl)-1-(4-methoxyphenyl)-2,5-dihydro-1H-pyrrole-2,5-dione

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V009-2585

Molecular Formula

C32H31N5O4 (C32 H31 N5 O4)

Compound Name

3-(4-ethylpiperazin-1-yl)-4-(5-hydroxy-1,3-diphenyl-1H-pyrazol-4-yl)-1-(4-methoxyphenyl)-2,5-dihydro-1H-pyrrole-2,5-dione

IUPAC name

3-(4-ethylpiperazin-1-yl)-4-(5-hydroxy-13-diphenyl-1H-pyrazol-4-yl)-1-(4-methoxyphenyl)-25-dihydro-1H-pyrrole-25-dione

SMILES

CCN(CC1)CCN1C(C(N1c(cc2)ccc2OC)=O)=C(c(c(-c2ccccc2)nn2-c3ccccc3)c2O)C1=O

InChI

InChI=1S/C32H31N5O4/c1-3-34-18-20-35(21-19-34)29-27(30(38)36(32(29)40)23-14-16-25(41-2)17-15-23)26-28(22-10-6-4-7-11-22)33-37(31(26)39)24-12-8-5-9-13-24/h4-17,39H,3,18-21H2,1-2H3

InChI Key

PYABOHLIEKXVNU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19802620

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

549.63

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.459

Distribution Coefficient, logD

0.235

Water Solubility, LogSw

-3.61

Polar Surface Area

73.103

Acid Dissociation Constant (pKa)

3.95

Base Dissociation Constant (pKb)

6.60

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

21.90

V009-2585 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Nucleoside Mimetics Library (2197 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Antiviral
  • Infections
  • Cancer
  • Immune system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with V009-2585 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V009-2585?
Check Price and Availability of V009-2585, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V009-2585 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V009-2585
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V009-2585
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V009-2585 available by request